| Followers | 672 |
| Posts | 86163 |
| Boards Moderated | 0 |
| Alias Born | 05/25/2008 |
Recent HOWL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 08:11:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 10:26:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:41:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2026 09:54:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/29/2025 09:48:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/22/2025 09:56:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 01:24:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/10/2025 10:01:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/24/2025 09:31:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2025 12:11:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 12:07:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 08:33:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 11:11:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 11:06:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 08:10:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 08:10:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 08:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 08:10:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 08:05:26 PM
- HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124 • GlobeNewswire Inc. • 05/20/2025 08:01:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/08/2025 08:07:58 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
